by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Email this page to a friend
Search this issue
Index - jump to page or section
Archive - view past issues
Australian Journal of Pharmacy : December 2005
Wyeth Consumer Healthcare Pty Ltd ABN 75 000 477 154. 17-19 Solent Circuit, Norwest Business Park, Baulkham Hills NSW 2153 Ph: (02) 9762 6100. Fax: (02) 9023 0010. Toll Free: 1800 283 195. www.wyethconsumer.com.au. 1. Sambrook PN, et al. Preventing osteoporosis: outcomes of the Australian Fracture Prevention Summit. Med J Aust 2002;176:S1-S16. 2. Fosamax Product Information. MIMS Annual, 2004. 3. Evista Product Information. MIMS Annual, 2004. 4. Premia Product Information. MIMS Annual, 2004. 5. Australian Bureau of Statistics. National Nutrition Survey. Nutrient intakes and physical measurements, Australia 1995. (Cat. No: 4805.0). 6. National Health and Medical Research Council. Recommended dietary intakes for use in Australia. AGPS Canberra, 1991. ® Registered Trademark. Are your osteoporosis patients rebuilding their bones? • Bisphosphonates, SERMs† and HRT‡ inhibit bone resorption in postmenopausal women,2-4 but do not replace calcium • Calcium supplements are recommended for women taking these therapies, when dietary calcium is inadequate 2-3 * • 84% of Australian women 55 years and over do not get enough dietary calcium5 One of the things you can do to help patients with osteoporosis is to make sure they have adequate calcium intake. Caltrate is an ideal daily calcium supplement. Each tablet provides 600mg of elemental calcium, equivalent to 60-75% of the calcium Recommended Dietary Intake6 for adults††-- plus it's lactose and gluten free. Assists in preventing & treating osteoporosis. Available on PBS restricted benefit For full active ingredients see the labels McNABB WL7325 Bisphosphonates, SERMs and HRT are first line therapies for osteoporosis, but are they enough? † Selective Oestrogen Receptor Modulators. ‡ Hormone Replacement Therapy * Bisphosphonates and Caltrate must be administered at different times of the day -- bisphosphonates 30 minutes before food; Caltrate after a meal. †† Except pregnant or lactating.